Wardill, H. R. http://orcid.org/0000-0002-6613-3661
Sonis, S. T. http://orcid.org/0000-0001-6480-2625
Blijlevens, N. M. A. http://orcid.org/0000-0002-1801-2072
Van Sebille, Y. Z. A. http://orcid.org/0000-0002-5803-3230
Ciorba, M. A. http://orcid.org/0000-0002-7656-0982
Loeffen, E. A. H. http://orcid.org/0000-0003-4514-3358
Cheng, K. K. F. http://orcid.org/0000-0002-4760-4771
Bossi, P. http://orcid.org/0000-0003-0135-0224
Porcello, L. http://orcid.org/0000-0002-6077-6631
Castillo, D. A. http://orcid.org/0000-0003-3406-9818
Elad, S. http://orcid.org/0000-0002-0044-9719
Bowen, J. M. http://orcid.org/0000-0003-0876-0031
,
Article History
Received: 10 May 2020
Accepted: 12 June 2020
First Online: 26 June 2020
Compliance with ethical standards
:
: Dr. Sonis reports personal fees from Biomodels, LLC, personal fees from Primary Endpoint Solutions, LLC, outside of the submitted work. As an employee of Biomodels and PES, he is involved in assisting industry, government and academics in the study and enablement of drugs, biologicals and devices to treat patients for a broad range of indications including cancer and oral toxicities of cancer therapy. He does not have equity or receive payment from any of the companies’ clients.
: N/A
: N/A
: N/A
: N/A